Sensing cell stress and transformation through Vγ9Vδ2 T cell-mediated recognition of the isoprenoid pathway metabolites

Microbes and Infection

Volumn 7, Issue 3, 2005, Pages 503-509

  Bonneville, Marc ^a   Fournié, Jean Jacques ^b  

^a INSTITUT DE BIOLOGIE   (France)

^b CHU PURPAN   (France)

Author keywords

Gamma delta T cell receptor; Immunology; Isoprenoid biosynthesis; T lymphocytes

Indexed keywords

CELL RECEPTOR; ISOPRENOID; NATURAL KILLER CELL RECEPTOR NKG2D; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; B LYMPHOCYTE; BINDING SITE; BIOSYNTHESIS; CARCINOMA; CONCENTRATION (PARAMETERS); CONFORMATIONAL TRANSITION; CORRELATION ANALYSIS; CYTOLYSIS; DOWN REGULATION; HUMAN; ISOMERIZATION; LYMPHOCYTE ACTIVATION; LYMPHOMA; METABOLISM; METABOLITE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RECOGNITION; REVIEW; STRESS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR CELL; UPREGULATION;

EUKARYOTA; PROKARYOTA;

EID: 18044394756     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.03.004     Document Type: Short Survey

References (56)

1. P. Fisch, M. Malkovsky, S. Kovats, E. Sturm, E. Braakman, B.S. Klein, S.D. Voss, L.W. Morrissey, R. DeMars, and W.J. Welch Recognition by human V gamma 9/V delta 2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells Science 250 4985 1990 1269 1273
2. P. Constant, F. Davodeau, M.A. Peyrat, Y. Poquet, G. Puzo, M. Bonneville, and J.J. Fournie Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands Science 264 5156 1994 267 270
3. C. Behr, R. Poupot, M.A. Peyrat, Y. Poquet, P. Constant, P. Dubois, M. Bonneville, and J.J. Fournie Plasmodium falciparum stimuli for human gammadelta T cells are related to phosphorylated antigens of mycobacteria Infect. Immun. 64 8 1996 2892 2896
4. C. Belmant, E. Espinosa, R. Poupot, M.A. Peyrat, M. Guiraud, Y. Poquet, M. Bonneville, and J.J. Fournie 3-Formyl-1-butyl pyrophosphate A novel mycobacterial metabolite-activating human gammadelta T cells J. Biol. Chem. 274 45 1999 32079 32084
5. Y. Tanaka, S. Sano, E. Nieves, G. De Libero, D. Rosa, R.L. Modlin, M.B. Brenner, B.R. Bloom, and C.T. Morita Nonpeptide ligands for human gamma delta T cells Proc. Natl. Acad. Sci. USA 91 17 1994 8175 8179
6. Y. Tanaka, C.T. Morita, E. Nieves, M.B. Brenner, and B.R. Bloom Natural and synthetic non-peptide antigens recognized by human gamma delta T cells Nature 375 6527 1995 155 158
7. M.R. Burk, L. Mori, and G. De Libero Human V gamma 9-V delta 2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites Eur. J. Immunol. 25 7 1995 2052 2058
8. C.T. Morita, H.K. Lee, D.S. Leslie, Y. Tanaka, J.F. Bukowski, and E. Marker-Hermann Recognition of nonpeptide prenyl pyrophosphate antigens by human gammadelta T cells Microbes Infect. 1 3 1999 175 186
9. J. Feurle, E. Espinosa, S. Eckstein, F. Pont, V. Kunzmann, J.J. Fournie, M. Herderich, and M. Wilhelm Escherichia coli produces phosphoantigens activating human gamma delta T cells J. Biol. Chem. 277 1 2002 148 154
10. M. Hintz, A. Reichenberg, B. Altincicek, U. Bahr, R.M. Gschwind, A.K. Kollas, E. Beck, J. Wiesner, M. Eberl, and H. Jomaa Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta T cells in Escherichia coli FEBS Lett. 509 2 2001 317 322
11. Y. Poquet, M. Kroca, F. Halary, S. Stenmark, M.A. Peyrat, M. Bonneville, J.J. Fournie, and A. Sjostedt Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination Infect. Immun. 66 5 1998 2107 2114
12. S. Fischer, A. Scheffler, and D. Kabelitz Activation of human gamma delta T-cells by heat-treated mistletoe plant extracts Immunol. Lett. 52 2-3 1996 69 72
13. B. Altincicek, J. Moll, N. Campos, G. Foerster, E. Beck, J.F. Hoeffler, C. Grosdemange-Billiard, M. Rodriguez-Concepcion, M. Rohmer, A. Boronat, M. Eberl, and H. Jomaa Cutting edge, human gamma delta T cells are activated by intermediates of the 2-C-methyl-d-erythritol 4-phosphate pathway of isoprenoid biosynthesis J. Immunol. 166 6 2001 3655 3658
14. J.F. Bukowski, C.T. Morita, and M.B. Brenner Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea, implications for innate immunity Immunity 11 1 1999 57 65
15. V. Kunzmann, E. Bauer, and M. Wilhelm Gamma/delta T-cell stimulation by pamidronate New Engl. J. Med. 340 9 1999 737 738
16. V. Kunzmann, E. Bauer, J. Feurle, F. Weissinger, H.P. Tony, and M. Wilhelm Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma Blood 96 2 2000 384 392
17. H.J. Gober, M. Kistowska, L. Angman, P. Jeno, L. Mori, and G. De Libero Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells J. Exp. Med. 197 2 2003 163 168
18. K. Thompson, and M.J. Rogers Statins prevent bisphosphonate-induced gamma,delta-T-cell proliferation and activation in vitro J. Bone Miner Res. 19 2 2004 278 288
19. J.E. Dunford, K. Thompson, F.P. Coxon, S.P. Luckman, F.M. Hahn, C.D. Poulter, F.H. Ebetino, and M.J. Rogers Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates J. Pharmacol. Exp. Ther. 296 2 2001 235 242
20. M. Wilhelm, V. Kunzmann, S. Eckstein, P. Reimer, F. Weissinger, T. Ruediger, and H.P. Tony Gammadelta T cells for immune therapy of patients with lymphoid malignancies Blood 102 1 2003 200 206
21. F. Dieli, N. Gebbia, F. Poccia, N. Caccamo, C. Montesano, F. Fulfaro, C. Arcara, M.R. Valerio, S. Meraviglia, C. Di Sano, G. Sireci, and A. Salerno Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo Blood 102 6 2003 2310 2311
22. M. Rohmer The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants Nat. Prod. Rep. 16 5 1999 565 574
23. A.K. Kollas, E.C. Duin, M. Eberl, B. Altincicek, M. Hintz, A. Reichenberg, D. Henschker, A. Henne, I. Steinbrecher, D.N. Ostrovsky, R. Hedderich, E. Beck, H. Jomaa, and J. Wiesner Functional characterization of GcpE, an essential enzyme of the non-mevalonate pathway of isoprenoid biosynthesis FEBS Lett. 532 3 2002 432 436
24. W. Eisenreich, M. Schwarz, A. Cartayrade, D. Arigoni, M.H. Zenk, and A. Bacher The deoxyxylulose phosphate pathway of terpenoid biosynthesis in plants and microorganisms Chem. Biol. 5 9 1998 R221 R233
25. A. Hemmerlin, J.F. Hoeffler, O. Meyer, D. Tritsch, I.A. Kagan, C. Grosdemange-Billiard, M. Rohmer, and T.J. Bach Cross-talk between the cytosolic mevalonate and the plastidial methylerythritol phosphate pathways in tobacco bright yellow-2 cells J. Biol. Chem. 278 29 2003 26666 26676
26. H. Jomaa, J. Wiesner, S. Sanderbrand, B. Altincicek, C. Weidemeyer, M. Hintz, I. Turbachova, M. Eberl, J. Zeidler, H.K. Lichtenthaler, D. Soldati, and E. Beck Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs Science 285 5433 1999 1573 1576
27. Y. Boucher, and W.F. Doolittle The role of lateral gene transfer in the evolution of isoprenoid biosynthesis pathways Mol. Microbiol. 37 4 2000 703 716
28. C. Belmant, E. Espinosa, F. Halary, I. Apostolou, H. Sicard, M.A. Peyrat, A. Vercellone, P. Kourilsky, G. Gachelin, R. Poupot, M. Bonneville, and J.J. Fournie Conventional and non-conventional recognition of non-peptide antigens by T lymphocytes C. R. Acad. Sci. III 322 11 1999 919 924
29. E. Espinosa, C. Belmant, H. Sicard, R. Poupot, M. Bonneville, and J.J. Fournie Y2K+1 state-of-the-art on non-peptide phosphoantigens, a novel category of immunostimulatory molecules Microbes Infect. 3 8 2001 645 654
30. J.F. Bukowski, C.T. Morita, H. Band, and M.B. Brenner Crucial role of TCR gamma chain junctional region in prenyl pyrophosphate antigen recognition by gamma delta T cells J. Immunol. 161 1 1998 286 293
31. F. Miyagawa, Y. Tanaka, S. Yamashita, B. Mikami, K. Danno, M. Uehara, and N. Minato Essential contribution of germline-encoded lysine residues in Jgamma1.2 segment to the recognition of nonpeptide antigens by human gammadelta T cells J. Immunol. 167 12 2001 6773 6779
32. F. Lang, M.A. Peyrat, P. Constant, F. Davodeau, J. David-Ameline, Y. Poquet, H. Vie, J.J. Fournie, and M. Bonneville Early activation of human V gamma 9V delta 2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands J. Immunol. 154 11 1995 5986 5994
33. C.T. Morita, E.M. Beckman, J.F. Bukowski, Y. Tanaka, H. Band, B.R. Bloom, D.E. Golan, and M.B. Brenner Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells Immunity 3 4 1995 495 507
34. T.J. Allison, C.C. Winter, J.J. Fournie, M. Bonneville, and D.N. Garboczi Structure of a human gammadelta T-cell antigen receptor Nature 411 6839 2001 820 824
35. W. Born, M.P. Happ, A. Dallas, C. Reardon, R. Kubo, T. Shinnick, P. Brennan, and R. O'Brien Recognition of heat shock proteins and gamma delta cell function Immunol. Today 11 2 1990 40 43
36. P. Fisch, A. Moris, H.G. Rammensee, and R. Handgretinger Inhibitory MHC class I receptors on gammadelta T cells in tumour immunity and autoimmunity Immunol. Today 21 4 2000 187 191
37. B. Das, M.O. Mondragon, M. Sadeghian, V.B. Hatcher, and A.J. Norin A novel ligand in lymphocyte-mediated cytotoxicity, expression of the beta subunit of H+ transporting ATP synthase on the surface of tumor cell lines J. Exp. Med. 180 1 1994 273 281
38. F. Miyagawa, Y. Tanaka, S. Yamashita, and N. Minato Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen J. Immunol. 166 9 2001 5508 5514
39. V. Kunzmann, E. Kretzschmar, T. Herrmann, and M. Wilhelm Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons Immunology 112 3 2004 369 377
40. Y. Kato, Y. Tanaka, F. Miyagawa, S. Yamashita, and N. Minato Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens J. Immunol. 167 9 2001 5092 5098
41. F. Mami-Chouaib, C. Miossec, P. Del Porto, C. Flament, F. Triebel, and T. Hercend T cell target 1 (TCT.1), a novel target molecule for human non-major histocompatibility complex-restricted T lymphocytes J. Exp. Med 172 4 1990 1071 1082
42. F. Poccia, M.L. Gougeon, M. Bonneville, M. Lopez-Botet, A. Moretta, L. Battistini, M. Wallace, V. Colizzi, and M. Malkovsky Innate T-cell immunity to nonpeptidic antigens Immunol. Today 19 6 1998 253 256
43. F. Halary, J.J. Fournie, and M. Bonneville Activation and control of self-reactive gammadelta T cells Microbes Infect. 1 3 1999 247 253
44. E. Vivier, and N. Anfossi Inhibitory NK-cell receptors on T cells, witness of the past, actors of the future Nat. Rev. Immunol. 4 3 2004 190 198
45. F. Halary, M.A. Peyrat, E. Champagne, M. Lopez-Botet, A. Moretta, L. Moretta, H. Vie, J.J. Fournie, and M. Bonneville Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors Eur. J. Immunol. 27 11 1997 2812 2821
46. P. Fisch, E. Meuer, D. Pende, S. Rothenfusser, O. Viale, S. Kock, S. Ferrone, D. Fradelizi, G. Klein, L. Moretta, H.G. Rammensee, T. Boon, P. Coulie, and P. van der Bruggen Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity Eur. J. Immunol. 27 12 1997 3368 3379
47. F. Poccia, B. Cipriani, S. Vendetti, V. Colizzi, Y. Poquet, L. Battistini, M. Lopez-Botet, J.J. Fournie, and M.L. Gougeon CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes J. Immunol. 159 12 1997 6009 6017
48. J. Michaelsson, C. Teixeira de Matos, A. Achour, L.L. Lanier, K. Karre, and K. Soderstrom A signal peptide derived from HSP60 binds HLA-E and interferes with CD94/NKG2A recognition J. Exp. Med. 196 11 2002 1403 1414
49. D.H. Raulet Roles of the NKG2D immunoreceptor and its ligands Nat. Rev. Immunol. 3 10 2003 781 790
50. H. Das, V. Groh, C. Kuijl, M. Sugita, C.T. Morita, T. Spies, and J.F. Bukowski MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function Immunity 15 1 2001 83 93
51. A. Diefenbach, E. Tomasello, M. Lucas, A.M. Jamieson, J.K. Hsia, E. Vivier, and D.H. Raulet Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D Nat. Immunol. 3 12 2002 1142 1149
52. M.R. Verneris, M. Karami, J. Baker, A. Jayaswal, and R.S. Negrin Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells Blood 103 8 2004 3065 3072
53. P. Andre, R. Castriconi, M. Espeli, N. Anfossi, T. Juarez, S. Hue, H. Conway, F. Romagne, A. Dondero, M. Nanni, S. Caillat-Zucman, D.H. Raulet, C. Bottino, E. Vivier, A. Moretta, and P. Paul Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors Eur. J. Immunol. 34 4 2004 961 971
54. C. Vitale, L. Chiossone, G. Morreale, E. Lanino, F. Cottalasso, S. Moretti, G. Dini, L. Moretta, and M.C. Mingari Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation Eur. J. Immunol. 34 2 2004 455 460
55. C.M. Parker, V. Groh, H. Band, S.A. Porcelli, C. Morita, M. Fabbi, D. Glass, J.L. Strominger, and M.B. Brenner Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire J. Exp. Med. 171 5 1990 1597 1612
56. A. Bendelac, M. Bonneville, and J.F. Kearney Autoreactivity by design, innate B and T lymphocytes Nat. Rev. Immunol. 1 3 2001 177 186